XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,231,784 | -75.9% | 34,417 | -73.4% | 0.03% | -78.5% |
| Q4 2022 | $5,102,912 | +37.3% | 129,417 | +25.7% | 0.12% | +39.1% |
| Q3 2022 | $3,717,000 | -29.0% | 102,977 | -40.2% | 0.09% | -37.0% |
| Q2 2022 | $5,234,000 | +496.8% | 172,071 | +500.0% | 0.14% | +527.3% |
| Q1 2022 | $877,000 | +33.7% | 28,679 | -42.6% | 0.02% | +4.8% |
| Q4 2019 | $656,000 | +45.5% | 50,000 | 0.0% | 0.02% | +16.7% |
| Q3 2019 | $451,000 | -8.5% | 50,000 | 0.0% | 0.02% | +50.0% |
| Q2 2019 | $493,000 | -3.0% | 50,000 | 0.0% | 0.01% | -25.0% |
| Q1 2019 | $508,000 | +60.8% | 50,000 | 0.0% | 0.02% | +23.1% |
| Q4 2018 | $316,000 | +59.6% | 50,000 | +233.3% | 0.01% | +225.0% |
| Q3 2018 | $198,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |